Literature DB >> 4005291

Purification of a new cytochrome P-450 from human liver microsomes.

P Beaune, J P Flinois, L Kiffel, P Kremers, J P Leroux.   

Abstract

Using a classical methodology of purification consisting of three chromatographic steps (Octyl-Sepharose, DEAE-cellulose, CM-cellulose) we have purified a new cytochrome P-450 from human liver microsomes. It was called cytochrome P-450(9). It has been proven to be different from all precedingly purified human liver microsomal cytochrome P-450 isozymes by its immunological and electrophoretical properties. It does not cross-react with any rat liver cytochrome P-450 and anti-cytochrome P-450(9) does not recognize rat liver microsomes; thus this cytochrome P-450(9) is specific to humans. This cytochrome P-450 isozyme exists in low amounts in human liver microsomes and exhibits an important quantitative polymorphism. In reconstituted system, cytochrome P-450(9) is able to hydroxylate all substrates tested but is not specific of any; its exact role in xenobiotic metabolism in man remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005291     DOI: 10.1016/0304-4165(85)90216-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

Authors:  M Bourdi; D Larrey; J Nataf; J Bernuau; D Pessayre; M Iwasaki; F P Guengerich; P H Beaune
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 2.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

3.  Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.

Authors:  P Beaune; P M Dansette; D Mansuy; L Kiffel; M Finck; C Amar; J P Leroux; J C Homberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38.

Authors:  L Massaad; G G Chabot; C Toussaint; S Koscielny; J Morizet; M C Bissery; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Expression of cytochrome P450 3A4 in foveolar epithelium with intestinal metaplasia of the human stomach.

Authors:  T Yokose; M Doy; M Kakiki; T Horie; Y Matsuzaki; K Mukai
Journal:  Jpn J Cancer Res       Date:  1998-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.